As of 2024-10-14, the Relative Valuation of Utah Medical Products Inc (UTMD) is 160.22 USD. This relative valuation is based on P/E multiples. With the latest stock price at 66.33 USD, the upside of Utah Medical Products Inc based on Relative Valuation is 141.6%.
The range of the Relative Valuation is 132.64 - 232.10 USD.
| Range | Selected | |
| Trailing P/E multiples | 38.6x - 51.7x | 40.8x |
| Forward P/E multiples | 33.6x - 37.5x | 34.7x |
| Fair Price | 132.64 - 232.10 | 160.22 |
| Upside | 100.0% - 249.9% | 141.6% |
| Date | P/E |
| 2024-10-14 | 14.81 |
| 2024-10-11 | 14.76 |
| 2024-10-10 | 14.65 |
| 2024-10-09 | 14.62 |
| 2024-10-08 | 14.47 |
| 2024-10-07 | 14.49 |
| 2024-10-04 | 14.48 |
| 2024-10-03 | 14.53 |
| 2024-10-02 | 14.60 |
| 2024-10-01 | 14.69 |
| 2024-09-30 | 14.89 |
| 2024-09-27 | 14.85 |
| 2024-09-26 | 14.89 |
| 2024-09-25 | 14.84 |
| 2024-09-24 | 14.85 |
| 2024-09-23 | 14.78 |
| 2024-09-20 | 14.76 |
| 2024-09-19 | 15.14 |
| 2024-09-18 | 14.96 |
| 2024-09-17 | 14.93 |
| 2024-09-16 | 15.00 |
| 2024-09-13 | 15.14 |
| 2024-09-12 | 14.67 |
| 2024-09-11 | 14.72 |
| 2024-09-10 | 14.72 |
| 2024-09-09 | 14.72 |
| 2024-09-06 | 14.74 |
| 2024-09-05 | 14.76 |
| 2024-09-04 | 14.86 |
| 2024-09-03 | 14.86 |
| 2024-08-30 | 15.13 |
| 2024-08-29 | 15.12 |
| 2024-08-28 | 15.19 |
| 2024-08-27 | 15.13 |
| 2024-08-26 | 15.21 |
| 2024-08-23 | 15.26 |
| 2024-08-22 | 15.04 |
| 2024-08-21 | 15.00 |
| 2024-08-20 | 14.95 |
| 2024-08-19 | 15.11 |
| 2024-08-16 | 15.20 |
| 2024-08-15 | 15.20 |
| 2024-08-14 | 14.71 |
| 2024-08-13 | 14.90 |
| 2024-08-12 | 14.80 |
| 2024-08-09 | 14.83 |
| 2024-08-08 | 14.90 |
| 2024-08-07 | 14.69 |
| 2024-08-06 | 14.69 |
| 2024-08-05 | 14.65 |